Showing results (261-270 of 309) with videos related to
Sort By:
Pageof 31
International Journal of Clinical Oncology|March 24, 2019
Future projection of cancer patients with cardiovascular disease in Japan by the year 2039: a pilot studyYuji Okura, Tsugumi Takayama, Kazuyuki Ozaki, et al.Science Signaling|July 18, 2023
The <i>Helicobacter pylori</i> CagA oncoprotein disrupts Wnt/PCP signaling and promotes hyperproliferation of pyloric gland base cellsAtsushi Takahashi-Kanemitsu, Mengxue Lu, Christopher Takaya Knight, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2011
Cord blood transplantation from unrelated donors for children with acute lymphoblastic leukemia in Japan: the impact of methotrexate on clinical outcomesKoji Kato, Ayami Yoshimi, Etsuro Ito, et al.Nature Communications|May 31, 2012
The Dishevelled-associating protein Daple controls the non-canonical Wnt/Rac pathway and cell motilityMaki Ishida-Takagishi, Atsushi Enomoto, Naoya Asai, et al.Nature|October 17, 2008
Oncogenic mutations of ALK kinase in neuroblastomaYuyan Chen, Junko Takita, Young Lim Choi, et al.Pediatric Blood & Cancer|October 27, 2009
Retrospective analysis of non-anaplastic peripheral T-cell lymphoma in pediatric patients in JapanRyoji Kobayashi, Kazumi Yamato, Fumiko Tanaka, et al.The Journal of Pathology|October 8, 2021
RAF1-MEK/ERK pathway-dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formationShinsuke Fujii, Takuma Ishibashi, Megumi Kokura, et al.International Journal of Hematology|June 19, 2014
Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children's Cancer Study Group (TCCSG) clinical trialsMotohiro Kato, Atsushi Manabe, Katsuyoshi Koh, et al.Iscience|July 17, 2023
Wnt5a-YAP signaling axis mediates mechanotransduction in cardiac myocytes and contributes to contractile dysfunction induced by pressure overloadHiroshi Kishimoto, Masayoshi Iwasaki, Kensaku Wada, et al.British Journal of Haematology|October 30, 2013
No impact of high-dose cytarabine and asparaginase as early intensification with intermediate-risk paediatric acute lymphoblastic leukaemia: results of randomized trial TCCSG study L99-15Motohiro Kato, Katsuyoshi Koh, Atsushi Manabe, et al.Pageof 31